ArticleCell death discovery2021

Interrogation of novel CDK2/9 inhibitor fadraciclib (CYC065) as a potential therapeutic approach for AML.

Wittawat Chantkran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.